Search research articles
Contact Us
Filters
Showing results (61-70 of 154) with videos related to
Page
of 16
Sort By:
Journal of Clinical Medicine
|
July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary Report
Gian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Cancer
|
February 2, 2019
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors
Mariella D'Adda, Mirko Farina, Francesca Schieppati, et al.
World Journal of Gastrointestinal Surgery
|
September 26, 2022
From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s
Francesco Auriemma, Sandro Sferrazza, Mario Bianchetti, et al.
Advances in Radiation Oncology
|
February 6, 2025
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma
Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Cancers
|
October 14, 2022
Prognostic Relevance of <i>NPM1</i> and <i>FLT3</i> Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience
Erika Borlenghi, Chiara Cattaneo, Diego Bertoli, et al.
Haematologica
|
August 11, 2019
An increase in <i>MYC</i> copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens
Francesca Schieppati, Piera Balzarini, Simona Fisogni, et al.
Cytotherapy
|
October 29, 2025
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus"
Domenico Russo, Mirko Farina, Gabriele Magliano, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related Prognosis
Erika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Blood
|
June 22, 2007
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini, Francesco Zaja, Caterina Patti, et al.
Annals of Hematology
|
April 5, 2022
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
Doriana Gramegna, Diego Bertoli, Chiara Cattaneo, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 154) with videos related to
Sort By:
Page
of 16
Journal of Clinical Medicine
|
July 29, 2020
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with <i>Bifidobacterium Longum</i> ES1 for 8 or 12 Weeks: A Preliminary Report
Gian Paolo Caviglia, Alessandra Tucci, Rinaldo Pellicano, et al.
Cancer
|
February 2, 2019
The e13a2 BCR-ABL transcript negatively affects sustained deep molecular response and the achievement of treatment-free remission in patients with chronic myeloid leukemia who receive tyrosine kinase inhibitors
Mariella D'Adda, Mirko Farina, Francesca Schieppati, et al.
World Journal of Gastrointestinal Surgery
|
September 26, 2022
From advanced diagnosis to advanced resection in early neoplastic colorectal lesions: Never-ending and trending topics in the 2020s
Francesco Auriemma, Sandro Sferrazza, Mario Bianchetti, et al.
Advances in Radiation Oncology
|
February 6, 2025
Impact of the Number of Administered Systemic Treatment Lines on Local Response to Radiation Therapy for Multiple Myeloma
Andrea Emanuele Guerini, Eneida Mataj, Paolo Borghetti, et al.
Cancers
|
October 14, 2022
Prognostic Relevance of <i>NPM1</i> and <i>FLT3</i> Mutations in Acute Myeloid Leukaemia, Longterm Follow-Up-A Single Center Experience
Erika Borlenghi, Chiara Cattaneo, Diego Bertoli, et al.
Haematologica
|
August 11, 2019
An increase in <i>MYC</i> copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens
Francesca Schieppati, Piera Balzarini, Simona Fisogni, et al.
Cytotherapy
|
October 29, 2025
Letter in response to "Overcoming barriers to referral for CAR T-cell therapy in patients with non-Hodgkin aggressive B-cell lymphomas: a Delphi Consensus"
Domenico Russo, Mirko Farina, Gabriele Magliano, et al.
Mediterranean Journal of Hematology and Infectious Diseases
|
November 13, 2024
Older Adults with Ph Negative Acute Lymphoblastic Leukemia: A Monocentric Experience on 57 Patients Focusing on Treatment Intensity and Age-Related Prognosis
Erika Borlenghi, Tatiana Zollner, Giuseppe Rossi, et al.
Blood
|
June 22, 2007
Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial
Andrea Gallamini, Francesco Zaja, Caterina Patti, et al.
Annals of Hematology
|
April 5, 2022
The role of clonal hematopoiesis as driver of therapy-related myeloid neoplasms after autologous stem cell transplantation
Doriana Gramegna, Diego Bertoli, Chiara Cattaneo, et al.
Page
of 16